NR - Avivagen Presents Canine Supplement at PEI Ho Avivagen Presents Canine Supplement at PEI Home Show
OTTAWA, ONTARIO, March 27, 2012 - Avivagen Animal Health Inc., the wholly-owned commercial arm of Chemaphor Inc. (TSX Venture Exchange: CFR), exhibited at the 2012 PEI Provincial Home Show, the largest consumer trade show on Prince Edward Island on March 9-11. The event drew 11,900 attendees.
The Avivagen team discussed the benefits of Oximunol(TM) Chewables with many interested dog owners and sampled over 500 Oximunol Chewables to eager and excited dog owners. Attendees at the show ranged from pet parents to owners of Boarding and Doggie Daycare facilities, groomers, breeders and agility competitors.
Dr. Jamie Nickerson, Avivagen's Director of Biology in Charlottetown, considered the event a great success. "For me, it was a fantastic opportunity to personally meet with dog owners and highlighted the fact that there is a genuine need for our product in the segment of natural animal health.", said Nickerson. "Dog owners were very excited to hear that one small tablet can offer so many different benefits to their dog. It was a gratifying experience and I am already looking forward to next year's show."
"We found one thing that interested people at our booth was the need for less vacuuming at home due to improved skin and coat health of dogs on Oximunol", said Ashley Craswell, Atlantic Sales Representative. "Once we mentioned that Oximunol assists the natural immune system and as a result has a positive impact on mobility and allows greater walk enjoyment and overall general health for their dogs, people were very eager to take Oximunol home with them to try it out with their own dog." Avivagen staff are following up via email, phone, Facebook and Twitter on the progress of the 500+ PEI dogs currently sampling Oximunol(TM) Chewables.
About Avivagen
Avivagen, a wholly-owned subsidiary of Chemaphor, is dedicated to improving the quality of life of animals through science-based, natural health products proven in clinical trials. More information can be found at www.avivagen.com.
About Chemaphor
Chemaphor, a wellness company, is committed to developing and delivering products for animals and humans to assist in optimizing health and daily quality of life. Chemaphor is advancing product candidates for the food animal market, companion animal market and various potential human applications. More information can be found at www.chemaphor.com.
Forward Looking Statements This news release includes certain forward-looking statements that are based upon current expectations, which involve risks and uncertainties associated with the business of Chemaphor Inc. and Avivagen Animal Health Inc. and the environment in which their respective businesses operate. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions "will", "anticipate", "believe", "plan", "estimate", "expect", "intend", and similar expressions. The forward-looking statements reflect the current expectations of Chemaphor Inc. and Avivagen Animal Health Inc. regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Chemaphor assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements. The results of treatment described above are based on historical results. Different animals may experience different results from the treatments described above.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For more information:
David Hankinson Graham Burton, PhD
CEO, Chemaphor Inc. President and Co-Founder, Chemaphor Inc.
Phone: 902-825-9270 Phone: 613-990-0969
d.hankinson@chemaphor.com g.burton@chemaphor.com
Copyright (c) 2012 Thenewswire.ca - All rights reserved.